Asthma. Asthma
Conditions
Interventions
Intervention 1: Patient in the case group will receive appropriate Asthma controller according their Asthma stage which is inhaled oral corticosteroid with appropriate dose and extra than standard ast
Treatment - Drugs
Patient in the case group will receive appropriate Asthma controller according their Asthma stage which is inhaled oral corticosteroid with appropriate dose and extra than standard asthma treatment th
Patients in the control group only receive asthma controller drug as oral inhaler corticosteroid according their asthma stage with appropriate dose without any supplementation.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 10-50; Asthma diagnosis according to spirometry and GINA guidlines; Ruled out of COPD and any chronic lung diseases; No asthma attack in previous 3 months; No pregnancy; No malignancy; sarcoidosis; renal or intestinal diseases or hyper sensitivity to vitamin D; No use of systemic corticoesteroid or anti convulsant Exclusion criteria No inclusion criteria; No consent to this program
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Airway function. Timepoint: Before and after 8week, 16 week and after 6month. Method of measurement: Oscilometry.;Airway function. Timepoint: Before and after 8week, 16 week and after 6month. Method of measurement: Spirometry.;Serum vitamin D level. Timepoint: Before and after 8week, 16 week and after 6month. Method of measurement: eliza (serum). | — |
Secondary
| Measure | Time frame |
|---|---|
| Serume Ig E level. Timepoint: before and after study. Method of measurement: ELIZA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMorteza Fallahpour
Tehran University of Medical Sciences
Outcome results
None listed